NM_001165958.2:c.407+536A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001165958.2(GSDMB):c.407+536A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 151,922 control chromosomes in the GnomAD database, including 28,691 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.60 ( 28691 hom., cov: 31)
Consequence
GSDMB
NM_001165958.2 intron
NM_001165958.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.205
Publications
37 publications found
Genes affected
GSDMB (HGNC:23690): (gasdermin B) This gene encodes a member of the gasdermin-domain containing protein family. Other gasdermin-family genes are implicated in the regulation of apoptosis in epithelial cells, and are linked to cancer. Alternative splicing and the use of alternative promoters results in multiple transcript variants. Additional variants have been described, but they are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to be protein-coding. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.79 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.600 AC: 91119AN: 151804Hom.: 28648 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
91119
AN:
151804
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.600 AC: 91209AN: 151922Hom.: 28691 Cov.: 31 AF XY: 0.599 AC XY: 44447AN XY: 74216 show subpopulations
GnomAD4 genome
AF:
AC:
91209
AN:
151922
Hom.:
Cov.:
31
AF XY:
AC XY:
44447
AN XY:
74216
show subpopulations
African (AFR)
AF:
AC:
33059
AN:
41472
American (AMR)
AF:
AC:
9029
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
1951
AN:
3466
East Asian (EAS)
AF:
AC:
3774
AN:
5172
South Asian (SAS)
AF:
AC:
2790
AN:
4826
European-Finnish (FIN)
AF:
AC:
4612
AN:
10490
Middle Eastern (MID)
AF:
AC:
191
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34234
AN:
67924
Other (OTH)
AF:
AC:
1271
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1773
3546
5319
7092
8865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2180
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.